Phase Ib trial of gemcitabine with yttrium-90 in patients with hepatic metastasis of pancreatobiliary origin

BACKGROUND: Gemcitabine, a chemotherapy for hepatic metastasis with pancreatic cancer (PC) or intrahepatic cholangiocarcinoma (ICC) origin, may radiosensitize the targeted tumor cells for yttrium-90 radioembolization (90Y-RE). This clinical trial was designed to investigate the effects of a combinat...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Gastrointest Oncol
Main Authors: Nezami, Nariman, Camacho, Juan C., Kokabi, Nima, El-Rayes, Bassel F., Kim, Hyun S.
Format: Artigo
Sprog:Inglês
Udgivet: AME Publishing Company 2019
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6776801/
https://ncbi.nlm.nih.gov/pubmed/31602333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2019.05.10
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker